Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Ningbo Menovo Pharmaceutical Co OCF Yield %?
Ningbo Menovo Pharmaceutical CoSHSE:603538 -1.67%58 OCF Yield % is 1.20 as of Jul. 16, 2026, which is 66% below its 10-year median of 3.48. GuruFocus rates SHSE:603538 with a GF Score™ of 58/100 and a GF Value™ of ¥16.25 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Ningbo Menovo Pharmaceutical Co ranks worse than 63.36% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Ningbo Menovo Pharmaceutical Co OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Ningbo Menovo Pharmaceutical Co OCF Yield % Related Terms
Ningbo Menovo Pharmaceutical Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Ningbo Menovo Pharmaceutical Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ningbo Menovo Pharmaceutical Co OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ningbo Menovo Pharmaceutical Co's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Ningbo Menovo Pharmaceutical Co's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ningbo Menovo Pharmaceutical Co (SHSE:603538) has a OCF Yield % of 1.20 as of Jul. 16, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Ningbo Menovo Pharmaceutical Co and its competitors. This is 66% below median its historical median of 3.48. According to the industry distribution chart, Ningbo Menovo Pharmaceutical Co ranks #638 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 63.4%.
Is Ningbo Menovo Pharmaceutical Co's OCF Yield % too high?
Ningbo Menovo Pharmaceutical Co's current OCF Yield % of 1.20 is 66% below median its 10-year median of 3.48. The Drug Manufacturers industry median OCF Yield % is 3.39. Ningbo Menovo Pharmaceutical Co's value of 1.20 is 64.6% below this industry median. Based on the distribution chart, Ningbo Menovo Pharmaceutical Co ranks #638 out of 1007 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Ningbo Menovo Pharmaceutical Co has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ningbo Menovo Pharmaceutical Co's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ningbo Menovo Pharmaceutical Co ranks #638 out of 1007 companies for OCF Yield %. This places Ningbo Menovo Pharmaceutical Co in the lower half of its industry. The industry median OCF Yield % is 3.39. Ningbo Menovo Pharmaceutical Co's value of 1.20 is 64.6% below this benchmark. While the company's 10-year median is 3.48 vs. the industry median of 3.39, Ningbo Menovo Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.39, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ningbo Menovo Pharmaceutical Co's current OCF Yield % of 1.20 is 64.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Ningbo Menovo Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ningbo Menovo Pharmaceutical Co's current OCF Yield % is 1.20, which is 66% below median its own 10-year median of 3.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ningbo Menovo Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Ningbo Menovo Pharmaceutical Co (SHSE:603538) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥16.25, compared to a current price of ¥38.35 — trading 136% above its estimated fair value. The current OCF Yield % is 1.20, which is 66% below median its 10-year median of 3.48 and 64.6% below the Drug Manufacturers industry median of 3.39. Ningbo Menovo Pharmaceutical Co's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Ningbo Menovo Pharmaceutical Co (SHSE:603538), the current OCF Yield % is 1.20 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ningbo Menovo Pharmaceutical Co (SHSE:603538) Overvalued in 2026?
Based on GuruFocus' analysis, Ningbo Menovo Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥38.35 is trading 136% above its estimated GF Value™ of ¥16.25.
GuruFocus considers Ningbo Menovo Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for SHSE:603538:
OCF Yield %: 1.20 (66% below median its 10-year median of 3.48)
GF Value™: ¥16.25 vs. price of ¥38.35 (136% above fair value)
Industry Position: 64.6% below the Drug Manufacturers median (#638 of 1007)
No single metric tells the full story. See the SHSE:603538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ningbo Menovo Pharmaceutical Co Business Description
Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.
58GF Score
Get the complete analysis for SHSE:603538
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603538 has been successfully added to your 
